 |
| |
*Note
on course proficiencies*
YEAR 3
SEMESTER II
Advanced Therapeutics II
PHAR 5582
Course Description:
Clinical pharmacy practice and therapeutics. Requires integration
and application of pharmacologic and biopharmaceutical principles
to the treatment of specific disease states.
Cr. 5. (5-0).
Prerequisite:
Advanced Therapeutics I, PHAR 5581
Course Proficiencies:
The student will be able to:
- Describe the following (where applicable)
for the topic presented:
- pathophysiology as it relates to drug therapy choices.
signs, symptoms, and laboratory findings as responses to
drug therapy (therapeutic monitoring parameters).
- natural course as it relates to prognosis and response
to long term therapeutic measures, goals of therapy.
- Discuss the following concerning the treatment
of the diseases presented:
- drug(s) of choice and rationale for selection.
nonpharmacological treatment and its comparative role with
drug therapy.
nature of expected response to treatment including therapeutic
monitoring parameters.
- adverse effects of treatment.
- appropriateness of the treatment regimen.
- outcome measures and monitoring
strategies.
- Identify health promotional issues and
treatment strategies for the diseases presented, including cancer
screening, self examinations, support groups, behavioral modification,
compliance, and rehabilitation programs.
- Demonstrate the ability to counsel patients,
concerning the diseases presented, on the:
- strategies to prevent the disease
or to minimize progression of the disease or its complications.
- scope, nature and importance of the
therapeutic regimen, the risks and benefits of the treatment
plan.
- the correct use of medications, duration
of therapy, and methods to comply with the regimen.
- adverse reactions and drug interactions
associated with the therapeutic plan.
desired outcome of the therapeutic plan.
- Demonstrate the ability to participate
in the drug use decision making process concerning the diseases
presented, including:
- collecting and evaluating patient data
to determine health care options (prescription, nonprescription,
etc.).
- recommending to other health care
providers appropriate drug selection and formulation.
- establishing therapeutic objectives
and monitoring parameters for specific patient populations
(e.g. geriatric, pediatric, pregnant or lactating women,
immunosuppressed patients).
- providing drug therapy educational
programs to health care professionals,
design evaluations of drug use.
The specific disease discussed in Advanced
Therapeutics II include:
Cardiovascular Disorders
Respiratory Disorders
Psychiatric Disorders
Pediatric Disorders
Hematologic Disorders
Oncologic Disorders
Dermatologic Disorders
Ophthalmic Disorders
Urogenital Disorders
|
|
